Cargando…
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
BACKGROUND: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. RESULTS: This commentary of highlights has resulted in 23 different topics selected by each member of the...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973323/ https://www.ncbi.nlm.nih.gov/pubmed/33738618 http://dx.doi.org/10.1186/s41181-021-00128-x |
| _version_ | 1783666823952072704 |
|---|---|
| author | Aime, Silvio Al-Qahtani, Mohammed Behe, Martin Bormans, Guy Carlucci, Giuseppe DaSilva, Jean N. Decristoforo, Clemens Duatti, Adriano Elsinga, Philip H. Kopka, Klaus Li, Xiang-Guo Liu, Zhibo Mach, Robert H. Middel, Oskar Passchier, Jan Patt, Marianne Penuelas, Ivan Rey, Ana Scott, Peter J. H. Todde, Sergio Toyohara, Jun Vugts, Danielle Yang, Zhi |
| author_facet | Aime, Silvio Al-Qahtani, Mohammed Behe, Martin Bormans, Guy Carlucci, Giuseppe DaSilva, Jean N. Decristoforo, Clemens Duatti, Adriano Elsinga, Philip H. Kopka, Klaus Li, Xiang-Guo Liu, Zhibo Mach, Robert H. Middel, Oskar Passchier, Jan Patt, Marianne Penuelas, Ivan Rey, Ana Scott, Peter J. H. Todde, Sergio Toyohara, Jun Vugts, Danielle Yang, Zhi |
| author_sort | Aime, Silvio |
| collection | PubMed |
| description | BACKGROUND: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. RESULTS: This commentary of highlights has resulted in 23 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. CONCLUSION: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry. |
| format | Online Article Text |
| id | pubmed-7973323 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79733232021-04-12 Highlight selection of radiochemistry and radiopharmacy developments by editorial board Aime, Silvio Al-Qahtani, Mohammed Behe, Martin Bormans, Guy Carlucci, Giuseppe DaSilva, Jean N. Decristoforo, Clemens Duatti, Adriano Elsinga, Philip H. Kopka, Klaus Li, Xiang-Guo Liu, Zhibo Mach, Robert H. Middel, Oskar Passchier, Jan Patt, Marianne Penuelas, Ivan Rey, Ana Scott, Peter J. H. Todde, Sergio Toyohara, Jun Vugts, Danielle Yang, Zhi EJNMMI Radiopharm Chem Review BACKGROUND: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. RESULTS: This commentary of highlights has resulted in 23 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. CONCLUSION: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry. Springer International Publishing 2021-03-18 /pmc/articles/PMC7973323/ /pubmed/33738618 http://dx.doi.org/10.1186/s41181-021-00128-x Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Review Aime, Silvio Al-Qahtani, Mohammed Behe, Martin Bormans, Guy Carlucci, Giuseppe DaSilva, Jean N. Decristoforo, Clemens Duatti, Adriano Elsinga, Philip H. Kopka, Klaus Li, Xiang-Guo Liu, Zhibo Mach, Robert H. Middel, Oskar Passchier, Jan Patt, Marianne Penuelas, Ivan Rey, Ana Scott, Peter J. H. Todde, Sergio Toyohara, Jun Vugts, Danielle Yang, Zhi Highlight selection of radiochemistry and radiopharmacy developments by editorial board |
| title | Highlight selection of radiochemistry and radiopharmacy developments by editorial board |
| title_full | Highlight selection of radiochemistry and radiopharmacy developments by editorial board |
| title_fullStr | Highlight selection of radiochemistry and radiopharmacy developments by editorial board |
| title_full_unstemmed | Highlight selection of radiochemistry and radiopharmacy developments by editorial board |
| title_short | Highlight selection of radiochemistry and radiopharmacy developments by editorial board |
| title_sort | highlight selection of radiochemistry and radiopharmacy developments by editorial board |
| topic | Review |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973323/ https://www.ncbi.nlm.nih.gov/pubmed/33738618 http://dx.doi.org/10.1186/s41181-021-00128-x |
| work_keys_str_mv | AT aimesilvio highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT alqahtanimohammed highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT behemartin highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT bormansguy highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT carluccigiuseppe highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT dasilvajeann highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT decristoforoclemens highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT duattiadriano highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT elsingaphiliph highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT kopkaklaus highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT lixiangguo highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT liuzhibo highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT machroberth highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT middeloskar highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT passchierjan highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT pattmarianne highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT penuelasivan highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT reyana highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT scottpeterjh highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT toddesergio highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT toyoharajun highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT vugtsdanielle highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard AT yangzhi highlightselectionofradiochemistryandradiopharmacydevelopmentsbyeditorialboard |